Skip to main content
. 2018 Apr 27;23(9):1063–1075. doi: 10.1634/theoncologist.2017-0614

Table 4. Outcomes in the treatment of recurrent primary central nervous system tumors.

image

a

Composite of multiple studies.

Abbreviations: CR, complete response; EGFR, epidermal growth factor receptor; mAb, monoclonal antibody; MoA, mechanism of action; OS, overall survival; PFS, progression‐free survival; PR, partial response; q2w, every 2 weeks; q6w, every 6 weeks; SD, stable disease; TKI, tyrosine kinase inhibitor; VEGF, vascular endothelial growth factor.